ERCC1/BRCA1表达与基因多态性对是否使用顺铂化疗的晚期非小细胞肺癌患者的预后及预测价值
评价者:刘晓晴1, 文献合成者:苟兰英2

ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin
Reviewer: LIU Xiao-qing1, Literature Co-worker: GOU Lan-ying2
图1 患者的PFS和OS的比较